Immunotherapy Advances in the Management of Nonmelanoma Skin Cancers

Review the latest in the use of immunotherapies in the management of basal cell carcinoma, cutaneous squamous cell carcinoma, and Merkel cell carcinoma and best practices in identifying and managing immune-related adverse events associated with immunotherpies in a focused text module and expert commentary.

Share

Program Content

Activities

Immunotherapy in NMSCs
Immunotherapy Advances in the Management of Nonmelanoma Skin Cancers
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: May 09, 2023

Expires: May 08, 2024

Activities

Immunotherapy for NMSCs

Immunotherapy Advances in the Management of Nonmelanoma Skin Cancers
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 09, 2023

Activities

Neoadj Cemiplimab in cSCC
What You Need to Know About the Use of Neoadjuvant Cemiplimab in Advanced cSCC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 13, 2023

Faculty

cover img faculity

Crystal Aguh, MD

Associate Professor
Department of Dermatology
Johns Hopkins University School of Medicine
Baltimore, Maryland

cover img faculity

Zeynep Eroglu, MD

Assistant Professor of Oncologic Sciences
Department of Oncologic Sciences
University of South Florida
Associate Member
Department of Cutaneous Oncology
H. Lee Moffit Cancer Center & Research Institute
Tampa, Florida

cover img faculity

Bethany Withycombe, PharmD, BCOP

Clinical Pharmacy Specialist, Cutaneous Clinic
Moffit Cancer Center
Tampa, Florida

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc